Komori
Management planning7317Matsuya R&D Co.,LtdAutomobiles and transportation equipment

Business Plan and Growth Potential

Updated the results for the fiscal year ended March 2026 and progress in each business, and outlined growth initiatives including blood pressure monitor cuffs, production in Vietnam, and automated sewing machines. However, no earnings forecast for the fiscal year ending March 2027 is provided because the Company is expected to be delisted following the completion of Omron Healthcare's tender offer.

Worth reading
33Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
204
¥ million
Wording
Conditional
How definitive the wording is.

Items stated in the management plan

Annual update
Business Plan and Growth Potential
Statements about the use of capital
Payout ratio / DOE policyThe basic policy is to pay a year-end dividend once a year and provide stable and continuous returns to shareholders. The applicable period is thereafter. Numerical targets for the payout ratio and DOE are not disclosed.The payout ratio is the proportion of profit paid out as dividends, while DOE is the ratio of dividends to net assets.
Key initiatives
01Strengthen initiatives related to blood pressure monitor cuffs, including promoting process automation and reviewing the supply chain
02Strengthen the rehabilitation robot business, including efforts to introduce new products
03Enter new business areas, including wearable devices
04Ensure stable operation of the new plant in Vietnam and strengthen MIC's development capabilities
05Strengthen overseas sales of automated sewing machines
06Expand transactions in the airbag and car seat businesses
07Enter new business areas, including services to improve the efficiency of cutting processes and production management systems, etc.
08Development of airbags for drones
Plan assumptionsThe blood pressure monitor market is forecast to grow from US$4.28 billion in 2025 to US$7.99 billion in 2032, at a CAGR of 9.3%., The global automotive airbag market is forecast to grow from US$27.9 billion in 2025 to US$48.2 billion in 2030, at a CAGR of 11.51%., The global automotive seat market is forecast to grow from US$73.96 billion in 2025 to US$87.88 billion in 2032, at a CAGR of 3.51%., Consolidated net sales grew at a CAGR of 10.01% from the fiscal year ended March 2017 to the fiscal year ended March 2026., Growth in the hypertensive population, rising demand for rehabilitation associated with population aging, labor shortages in the healthcare industry, growing attention to low-cost labor in Vietnam, and rising labor costs due to labor shortages and wage increases
Non-financial targetsIndicator name Target headcount through automation / Target value Approximately 4 people / Timing Not disclosed
Size of the Target MarketMarket Blood pressure monitor market / Scale US$4.28 billion in 2025 and US$7.99 billion in 2032 / Growth rate CAGR9.3% / Source Coherent Market Insights, Market Global automotive airbag market / Scale US$27.9 billion in 2025 and US$48.2 billion in 2030 / Growth rate CAGR11.51% / Source Report Ocean, Market Global automotive seat market / Scale US$73.96 billion in 2025 and US$87.88 billion in 2032 / Growth rate CAGR3.51% / Source Mordor Intelligence, Market Rehabilitation-related market / Scale ¥182.3 billion in 2020 and a forecast ¥266.3 billion in 2030 / Growth rate Not disclosed / Source According to Fuji Keizai
Risks identified by the company
Dependence on transactions with specific customers
Overseas business activities
Quality control
Research and development
Recruitment and development of human resources
For other risks, refer to the Annual Securities Report, Part II: Business Overview, 3. Business and Other Risks
Reason for revision or withdrawal

As the tender offer by Omron Healthcare Co., Ltd. for the Company's shares and other securities was completed, the Company is expected to be delisted after completing the procedures for becoming a wholly owned subsidiary. Accordingly, no earnings forecast for the fiscal year ending March 2027 is provided.

Items stated in the management plan
ItemDetails
Plan nameBusiness Plan and Growth Potential
Progress against the planAnnual update
Payout ratio / DOE policyThe basic policy is to pay a year-end dividend once a year and provide stable and continuous returns to shareholders. The applicable period is thereafter. Numerical targets for the payout ratio and DOE are not disclosed.
Non-financial targetsIndicator name Target headcount through automation / Target value Approximately 4 people / Timing Not disclosed
Plan assumptionsThe blood pressure monitor market is forecast to grow from US$4.28 billion in 2025 to US$7.99 billion in 2032, at a CAGR of 9.3%., The global automotive airbag market is forecast to grow from US$27.9 billion in 2025 to US$48.2 billion in 2030, at a CAGR of 11.51%., The global automotive seat market is forecast to grow from US$73.96 billion in 2025 to US$87.88 billion in 2032, at a CAGR of 3.51%., Consolidated net sales grew at a CAGR of 10.01% from the fiscal year ended March 2017 to the fiscal year ended March 2026., Growth in the hypertensive population, rising demand for rehabilitation associated with population aging, labor shortages in the healthcare industry, growing attention to low-cost labor in Vietnam, and rising labor costs due to labor shortages and wage increases
Key initiativesStrengthen initiatives related to blood pressure monitor cuffs, including promoting process automation and reviewing the supply chain, Strengthen the rehabilitation robot business, including efforts to introduce new products, Enter new business areas, including wearable devices, Ensure stable operation of the new plant in Vietnam and strengthen MIC's development capabilities, Strengthen overseas sales of automated sewing machines, Expand transactions in the airbag and car seat businesses, Enter new business areas, including services to improve the efficiency of cutting processes and production management systems, etc., Development of airbags for drones
Reason for revision or withdrawalAs the tender offer by Omron Healthcare Co., Ltd. for the Company's shares and other securities was completed, the Company is expected to be delisted after completing the procedures for becoming a wholly owned subsidiary. Accordingly, no earnings forecast for the fiscal year ending March 2027 is provided.
Size of the Target MarketMarket Blood pressure monitor market / Scale US$4.28 billion in 2025 and US$7.99 billion in 2032 / Growth rate CAGR9.3% / Source Coherent Market Insights, Market Global automotive airbag market / Scale US$27.9 billion in 2025 and US$48.2 billion in 2030 / Growth rate CAGR11.51% / Source Report Ocean, Market Global automotive seat market / Scale US$73.96 billion in 2025 and US$87.88 billion in 2032 / Growth rate CAGR3.51% / Source Mordor Intelligence, Market Rehabilitation-related market / Scale ¥182.3 billion in 2020 and a forecast ¥266.3 billion in 2030 / Growth rate Not disclosed / Source According to Fuji Keizai
Risks identifiedDependence on transactions with specific customers, Overseas business activities, Quality control, Research and development, Recruitment and development of human resources, For other risks, refer to the Annual Securities Report, Part II: Business Overview, 3. Business and Other Risks
Items this document does not state (16)
Plan periodSales TargetOperating profit targetOperating profit margin targetNet income targetROE targetROIC targetTreasury share acquisition policyCost of capitalSelf-assessment of PBR and share priceTotal investment planInvestment amount by sectorSegment targetResults under the previous planDate of board resolutionPublication date

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

As the tender offer by Omron Healthcare Co., Ltd. was completed, the Company is expected to be delisted after completing the procedures for becoming a wholly owned subsidiary. Accordingly, no earnings forecast for the fiscal year ending March 2027 is provided.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Business Plan and Growth Potential | Matsuya R&D Co.,Ltd (7317) timely disclosure | Komori